drugset / Trial / NCT03820466
Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin
RandomizedParallel-groupDouble-blindPrevention
Summary
The study evaluates the effect of platelet inhibition and / or lipid lowering in non-ACS-patients with symptoms suggestive for ACS, and elevated high-sensitivity troponin values
Timeline
- Start
- 2020-02-21
- Primary completion
- 2021-12-02
- Completion
- 2022-04-07
Outcome
Outcome not reported
Stopped (Enrollment): “insufficient recruitment due to the pandemic situation”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 100 mg | — |
| Subject | Atorvastatin | Small molecule | 20 mg | — |